Today’s AI Top Pick: EPAM

7/27/2026 · Highly Shorted Deep Rotation RSI & Conf screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Deep Rotation RSI & ConfEPAMBUY NOW8.7 / 107/27/2026

EPAM is the cleanest multi-timeframe alignment in this pool with real fundamental support. Every single timeframe forecast points up and materially so: 1h fc_short +7.95%, 4h fc_short +26.73% / fc_long +92.56%, 1d fc_short +31.2% / fc_mid +59.05% / fc_long +73.9%, and 1wk fc_long +99.86%. Bullish_prob is 1.0 and near_term_bullish is a perfect 1.0 — the highest in the entire pool. That is the definition of 'the tape confirms.' The fundamentals back the setup rather than fight it. FwdPE 6.33, PEG 0.6, debt/equity 0.08 (essentially unlevered), ROE 10.93%, profit margin 6.96%, and analyst targetUpsidePct 51.3% with recom 1.86. This is not a story stock — it's a profitable IT-services franchise trading at a single-digit forward multiple after a -56% YTD / -46.82% one-year drawdown. Short float 18.93% adds squeeze fuel on any positive earnings print (EPAM has a history of beats, and consensus expects EPS growth of +8.83% next year off a depressed base). On the 'don't chase' test EPAM is nuanced but acceptable: 1h and 1d are pinned at 100% of the 21-bar range, which normally screams wait — but the weekly chart is only at 22.63% of its range with a -33.99% drawdown from the 21-bar high, meaning what looks toppy on intraday is actually a bounce off a deep weekly base. Confluence across four timeframes plus a weekly-oversold context is exactly the setup you want. News is clean: no guidance cut, no legal, no dilution — just a mild Insider Monkey retrospective and a Zacks beat-again preview. Why today vs. waiting: the daily/weekly forecast delta widens the longer you go (fc_short +31% vs fc_long +73.9%), and every day the market re-rates a name off a weekly base is a day of premium given up. Any pullback into the 86–88 zone is a gift; absent that, starting a position at 90.5 and adding on any 4h flush is the right posture.

Entry zone

$88.00–$91.50 (start half now near $90.50, add on any dip to $88 which aligns with 4h range midpoint)

Stop loss

$81.50 (below the 1wk drawdown floor — a close under here invalidates the weekly-base thesis)

First target

$105–$110 (aligns with 1d fc_short +31%, ~15–20% upside)

Longer target

$140–$160 (aligns with 4h fc_long +92.56% and 1wk fc_long +99.86%; also within striking distance of 51.3% analyst target upside)

Risks

Price is at 100% of 21-bar range on both 1h and 1d — a short-term mean-reversion pullback of 4–7% is a realistic near-term risk before the swing works.
18.93% short float cuts both ways: fuels the squeeze on good news but amplifies drawdowns on any earnings disappointment (next print is a binary event).
EPAM has ongoing revenue-mix / geopolitical exposure risk (Ukraine/Eastern Europe delivery base) that has historically caused sudden guidance resets; salesYoY is only 14.21%.
PE of 12.89 vs fwdPE 6.33 implies the Street is banking on a big EPS recovery — if guidance is merely 'in-line' the multiple can compress fast.
Weekly recent_21bar_pct is -33.99%: the base is real but a failed bounce here would confirm a lower-high pattern and trigger technical stop-outs.

Honorable mentions

MNDYFundamental_score 5.75 (tied top), bullish_prob 1.0, and the 1wk fc_long of +168.73% is the largest in the pool. The 20% layoff / AI pivot news is a bullish cost-cut catalyst, not a negative. Held back only by 1h at 100% range and near_term_bullish of 0.4 — better as a pullback buy to $73–74.

UPWKCheapest name that isn't broken: fwdPE 5.07, PEG 0.38, profit margin 13.81%, ROE 18.76%, targetUpside 40.9%, and weekly -27.19% drawdown gives real base. Held off #1 because interim-CFO news (Gessert medical leave) adds temporary execution overhang and 4h/1d forecasts (+42%/+44%) are strong but 1h is already negative (-2.91%).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	EPAM	BUY NOW	8.7	All-4-TF bullish forecasts, near_term_bullish 1.0, fwdPE 6.33 off a -56% YTD base — cleanest confluence in the pool.
2	MNDY	BUY PULLBACK	7.9	1wk fc_long +168.73% and cost-cut catalyst, but 1h pinned at 100% of range — wait for $73–74.
3	UPWK	BUY PULLBACK	7.6	Deep value (fwdPE 5.07, PEG 0.38) with strong 4h/1d forecasts; CFO leave is a temporary drag.
4	IT	BUY PULLBACK	7.3	ROE 94.87% and 1wk fc_long +153.66% off -15.97% base, but 1h at 100% range demands patience.
5	KVYO	BUY NOW	7.0	Citi PT hike to $34, salesYoY +30.27%, all-TF positive forecasts, 1h pos only 11.77% (not chased).
6	DXC	BUY PULLBACK	6.7	FwdPE 3.27 and 1wk fc_long +88.93% but PE 171.5 and razor-thin margins make it a lottery on execution.
7	OWL	BUY PULLBACK	6.6	Solid asset manager but near_term_bullish only 0.2 and 1h fc_short flat — earnings next week is the catalyst.
8	FOUR	BUY PULLBACK	6.4	PEG 0.48 with 4h/1d/1wk all positive but 1h fc_short -12.93% flags a near-term dip first.
9	INSP	BUY PULLBACK	6.2	Absurd 1wk fc_long +281.95% off -46.67% YTD, but recall overhang and targetUpside only 6.5% cap enthusiasm.
10	PPC	BUY NOW	6.1	PE 7.7, ROE 25.9%, near_term_bullish 0.8; Q2 earnings preview neutral, decent risk/reward.
11	YELP	BUY NOW	6.0	OpenAI/ChatGPT licensing deal is a real catalyst; 1h pos 0% means no chase, 1wk fc_long +51.16%.
12	SMCI	WAIT	5.7	Fantastic AI news but 1wk fc_long -24.83% and recom 3.0 warn the melt-up has already happened.
13	EYE	BUY PULLBACK	5.6	Insider buying at $15.5 supports thesis; all TFs positive but 1wk fc_mid negative and 1h at 100% range.
14	PROP	WAIT	5.2	4h fc_short +78% is spectacular but $78M cap, D/E 1222, -46% profit margin — pure speculation.
15	VRDN	WAIT	4.8	FDA-approved Lumvoa launch is real but 1h fc_short -21.37% and profit margin -482% keep risk high.
16	SAIL	WAIT	4.5	Entro acquisition and agentic-fabric story intact but 1h fc_short -7.62% and short float 33.95% cut both ways.
17	POST	WAIT	4.4	Defensive, PE 15.3, but Evercore lowered PT and 1h fc_short mixed — no urgency.
18	DFH	WAIT	4.2	PE 9.5 is cheap but insider selling and 1h/4h forecasts negative — homebuilder tape is unfriendly.
19	VIA	WAIT	4.0	1d fc_short -13.25% and no fundamentals footing; 1h at only 16.65% range warns of continued drift.
20	GCT	WAIT	3.9	Value-stock narrative but 1d/1wk forecasts turning negative and 1wk pos only 22.5%.
21	VSTM	WAIT	3.7	Verastem VS-7375 trial dose is positive but all forecast horizons -13% to -23% — a fade after the run.
22	ARDT	AVOID	3.4	Truist AND RBC both cut PTs; 1h/4h forecasts -8% to -24%, bullish_prob 0.
23	PTON	AVOID	3.3	All timeframes forecast down (-8% to -18%) and salesYoY -3.26% — the bounce is exhausted.
24	GRND	AVOID	3.2	Insider selling flagged, bullish_prob 0, D/E 470 — nothing here to press.
25	TRIP	AVOID	3.0	BTIG downgrade to Neutral on AI-risk, 1h fc_short -22.46%, targetUpside 0.6%.
26	CXT	AVOID	2.7	All four TFs at 100% of range AND all forecasts -10% to -34% — textbook 'priced for perfection.'
27	DLO	AVOID	2.6	Every timeframe forecast negative (-7% to -30%) despite Truist raise; director selling adds insult.
28	ABX	AVOID	2.5	Forecasts -15% to -29% across horizons; the +95% one-year run has borrowed all the future returns.
29	DAVE	AVOID	2.4	TargetUpside -3.5% and PS 8.47 after 82% YTD — mean reversion risk is severe.
30	TGTX	AVOID	2.0	1wk +103% run has produced fc_long -58.67%; PS 12.25 and every TF forecasting a crash.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord